eli lilly mounjaro news - Search News

Lilly weight-loss drug copycats dealt blow

YAHOO!Finance · 2h

Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list

GLP-1 weight-loss drugs Mounjaro and Zepbound have been removed from the Food and Drug Administration's (FDA) shortage list. Senior Health Reporter Anjalee Khemlani reports more on the story and what it means for competitors,

The Wall Street Journal on MSN · 13h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

The Washington Post · 21h

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

5h

NHS proposes phased launch for Eli Lilly’s Mounjaro

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

FiercePharma23h

NHS England proposes phased rollout for Eli Lilly's star obesity drug

While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...

Obesity Drug Shortage Ends for Lilly, Continues for Novo as Industry Bolsters Manufacturing

Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the ...

21h

Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant

The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results